It has been proposed that BECN1 acts as a tumor suppressor [36], and more recently, low levels of BECN1 have been linked to a worse prognosis in gastric, colorectal and pancreatic, as well as breast, cancer. This evidence concerns the gene BECN1 and neoplasm.